(BSCV) Invesco BulletShares 2031 - Ratings and Ratios
Corporate, Bonds, 2031, Investment-Grade
Dividends
| Dividend Yield | 4.64% |
| Yield on Cost 5y | 4.63% |
| Yield CAGR 5y | 76.59% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 2.86% |
| Value at Risk 5%th | 4.76% |
| Relative Tail Risk | 1.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.62 |
| Alpha | 2.18 |
| CAGR/Max DD | 0.75 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.310 |
| Beta | 0.061 |
| Beta Downside | 0.023 |
| Drawdowns 3y | |
|---|---|
| Max DD | 7.88% |
| Mean DD | 1.64% |
| Median DD | 1.38% |
Description: BSCV Invesco BulletShares 2031 November 17, 2025
The Invesco BulletShares 2031 Corporate Bond ETF (NASDAQ:BSCV) is a target-maturity fund that commits at least 80 % of its assets to U.S. dollar-denominated investment-grade corporate bonds whose contractual or effective maturities are centered on the year 2031. Its performance tracks an index designed to reflect the total return of that 2031-bond universe.
As of the latest quarterly report, BSCV carries an average effective duration of roughly 8.5 years and a weighted-average credit rating of A-, indicating moderate interest-rate sensitivity and a focus on high-quality issuers. The fund’s 30-day SEC yield hovers near 4.2 %, a figure that remains attractive relative to comparable Treasury-linked target-maturity products, especially as the Federal Reserve’s policy pivot toward lower rates could boost bond prices. Sector exposure is tilted toward industrials and consumer discretionary, which together account for about 45 % of holdings, making the ETF sensitive to corporate earnings trends and the broader health of the U.S. economy.
For a deeper dive into BSCV’s risk-adjusted performance metrics and how it fits within a diversified fixed-income strategy, you might explore the analytical tools on ValueRay.
What is the price of BSCV shares?
Over the past week, the price has changed by -0.24%, over one month by +0.62%, over three months by +1.03% and over the past year by +6.89%.
Is BSCV a buy, sell or hold?
What are the forecasts/targets for the BSCV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 18.6 | 11.1% |
BSCV Fundamental Data Overview December 03, 2025
Beta = 1.13
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.41b USD (1.41b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.41b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.41b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.24% (E(1.41b)/V(1.41b) * Re(6.24%) + (debt-free company))
Discount Rate = 6.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for BSCV ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle